Trademark: 97381872
Status Date
Tuesday, April 25, 2023
Registration Number
7036963
Registration Date
Tuesday, April 25, 2023
Filing Date
Tuesday, April 26, 2022
Published for Opposition
Tuesday, February 7, 2023
44 Medical testing for diagnostic or treatment purposes in the field of cancer and infectious diseases using an enrichment-based diagnostic NGS (Next Generation Sequencing) testing panel assay used for extracting and sequencing nucleic acid, DNA, RNA; Medical testing services relating to the diagnosis and treatment of disease
42 Laboratory research in the field of genomics and immuno-oncology, namely, product development in the nature of development of diagnostic molecular testing for analyzing disease and genome information, in particular an enrichment-based diagnostic NGS (Next Generation Sequencing) testing panel assay used for extracting and sequencing nucleic acid, DNA, RNA from cancer cells to detect mutations therein and provide assessment and information about such mutations for the purpose of evaluating and screening patients for clinical trials in planning medical treatment for and providing targeted therapy selection to cancer patients
Apr 25, 2023
Notice Of Registration Confirmation Emailed
Apr 25, 2023
Registered-Principal Register
Feb 7, 2023
Official Gazette Publication Confirmation E-Mailed
Feb 7, 2023
Published For Opposition
Jan 18, 2023
Notification Of Notice Of Publication E-Mailed
Jan 4, 2023
Approved For Pub - Principal Register
Dec 30, 2022
Teas/Email Correspondence Entered
Dec 29, 2022
Correspondence Received In Law Office
Dec 29, 2022
Teas Response To Office Action Received
Dec 2, 2022
Notification Of Non-Final Action E-Mailed
Dec 2, 2022
Non-Final Action E-Mailed
Dec 2, 2022
Non-Final Action Written
Nov 3, 2022
Assigned To Examiner
May 2, 2022
New Application Office Supplied Data Entered
Apr 29, 2022
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
